CD70 Targeting Therapies Clinical Trials Insight 2025: 20+ CD70 Targeting Therapies In Clinical Trials
31. Januar 2025 05:00 ET
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's offering. CD70...
CD47 Inhibitor Drug Clinical Trials Market Opportunity Outlook 2028, Competitive Analysis of Adagene, ALX, ImmuneOncia, ImmuneOnco, Light Chain Bioscience, Phanes, and Virtuoso,
29. Januar 2025 06:14 ET
|
Research and Markets
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. ...
Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025
28. Januar 2025 05:44 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...
Delta-like Ligand 3 (DLL3) Targeted Therapies Market Research 2025: 1 Drug, Imdelltra (Tarlatamab) Available / 10 Drugs by Company, Indication and Phase / Approved Drug Dosage, Sales & Pricing Insight
23. Januar 2025 07:51 ET
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "DLL3 Targeted Therapies Market, Approved Drugs, Dosage, Pricing & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's...
China Pharmaceutical Regulatory Affairs Training Course: How to Gain and Maintain a Successful Marketing Authorisation in the PRC, Including Hong Kong, Macau and Taiwan (ONLINE EVENT)
09. Januar 2025 09:12 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China Training Course" conference has been added to ResearchAndMarkets.com's offering. This seminar will provide...
Clinical Trials Management Systems (CTMS) Market Research, 2024-2035, by Solution Type, Component, Delivery Mode, End User, and Region with Detailed Company Profiles of Leading Players
03. Januar 2025 07:29 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Management System Market by Solution Type, by Component, by Delivery Mode, by End-User, and By Region" report has been added to ...
AI in Drug Discovery Strategic Intelligence Research Report 2024: Healthcare, Macroeconomic, Technology, and Regulatory Trends Impacts
20. Dezember 2024 09:49 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: AI in drug discovery" report has been added to ResearchAndMarkets.com's offering. This report consolidates the latest...
China Pioneers Innovative Drug Development with a Surge in CAR-T Cell and ADC Therapy Advancements
20. Dezember 2024 09:26 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Drug Development Trends in China" report has been added to ResearchAndMarkets.com's offering.China has emerged as a critical player in global drug...
Pharmaceutical Regulatory Affairs in China - 2 Day Online Training Course (March 31, 2025 April 1, 2025)
10. Dezember 2024 13:01 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China Training Course" has been added to ResearchAndMarkets.com's offering. This seminar will provide an...
CD40 Targeted Therapies Clinical Trials & Market Opportunity Report 2025, Insight By Company, Country, Indication & Phase
09. Dezember 2024 04:48 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...